Lumida
/TKNO
⌘K
Alpha Teknova Inc

Alpha Teknova Inc

TKNO
$5.42USD+1.88%+0.10 today

MARKET CAP

290.6M

P/E (TTM)

FWD P/E

DAY RANGE

$5 – $6

52W RANGE

$2
$7

AI Summary

Stalk
Buy NowMedium

TKNO is in a Stage 2 corrective advance with clear higher highs and higher lows, riding above rising 9/21 EMAs and 50 DMA. Price is tightly tracking above the EMAs and holding support on shallow pullbacks, with no exhaustion evident. The medium-term bias remains bullish, and short-term timing favors immediate participation; we Buy Now on support at the EMA zone while monitoring for flattening EMA slopes and failure to reclaim June highs as potential transition risk to Stage 3.

  • Q1 2026 revenue rose 13% YoY to $11M; clinical solutions up 85%
  • 2026 revenue guidance of $42–44M implies ~6% growth over 2025
  • Custom products (25% of sales) remain exposed to volatile biotech funding
Full analysis →
Insider Trades8 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Mar 6, 2026BuyTKNOStephen GunstreamPresident and CEO26,000$2.15$290.6M-18.86%+183.77%$55.8K+3.87%Buy Now
Mar 6, 2026BuyTKNOMatthew LowellChief Financial Officer40,000$2.19$290.6M-18.86%+183.77%$87.6K+13.36%Buy Now
Jul 12, 2024BuyTKNOMatthew LowellChief Financial Officer40,322$1.24$290.6M-18.86%+183.77%$50.0K+45.79%Buy Now
Jul 12, 2024BuyTKNOStephen GunstreamPresident and CEO80,645$1.24$290.6M-18.86%+183.77%$100.0K+49.52%Buy Now
Nov 30, 2023BuyTKNOKen GelhausChief Commercial Officer3,587$1.73$290.6M-18.86%+183.77%$6.2K+18.55%16bBuy Now
Sep 19, 2023BuyTKNODamon TerrillGeneral Counsel and CCO27,027$1.85$290.6M-18.86%+183.77%$50.0K+193.05%Buy Now
Sep 19, 2023BuyTKNOStephen GunstreamPresident and CEO54,054$1.85$290.6M-18.86%+183.77%$100.0K+49.68%Buy Now
Sep 19, 2023BuyTKNOMatthew LowellChief Financial Officer54,054$1.85$290.6M-18.86%+183.77%$100.0K+158.98%Buy Now